Skip to main content
Home > SciBX > Therapeutics

Chronological Index of SciBX: The Science-Business eXchange: Therapeutics

SciBX: The Science-Business eXchange Current Issue
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Neurology Unknown In vitro studies identified neurotrophic, secoyohimbane-derived compounds that could …

    Published on 5/9/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Transplantation Graft rejection Complement 3 (C3); C5a Mouse studies suggest a combination of C3 and C5a inhibition…

    Published on 5/9/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Brain cancer Fibroblast growth factor receptor 1 (FGFR1; CD331) Studies in mice …

    Published on 5/2/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer Dedicator of cytokinesis 1 (DOCK1) Patient sample and mouse studies…

    Published on 5/2/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Fibroblast growth factor receptor (FGFR) Two separate studies identified …

    Published on 5/2/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Liver cancer Calcium channel voltage-dependent a2/d subunit 1 (CACNA2D1) Mouse …

    Published on 5/2/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Pancreatic cancer Not applicable Mouse studies suggest radionuclide-labeled …

    Published on 5/2/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Diabetes Chemokine CX3C motif ligand 1 (CX3CL1; fractalkine);…

    Published on 5/2/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Hypercholesterolemia; hyperlipidemia; dyslipidemia SEC24 …

    Published on 5/2/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Hepatic disease Liver failure Mitogen-activated protein kinase kinase 4 (MAP2K4; MKK4) …

    Published on 5/2/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease HCV; HIV/AIDS Type I interferon receptor Mouse studies suggest …

    Published on 5/2/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Alzheimer's disease (AD) AMP-activated protein kinase (AMPK); b-amyloid 42 (…

    Published on 5/2/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Pain Fatty acid amide hydrolase (FAAH) Mouse and in vitro studies identified a…

    Published on 5/2/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Various Coronary artery disease (CAD); Parkinson's disease (PD) Myeloperoxidase (MPO) In…

    Published on 5/2/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Epoxide hydrolase 2 (EPHX2; CEH) Cell culture and mouse studies suggest a combination of fish oil-…

    Published on 4/25/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Colorectal cancer Proteasome 26S subunit non-ATPase 10 (PSMD10; gankyrin) Mouse and cell culture studies …

    Published on 4/25/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Colorectal cancer Tankyrase TRF1-interacting ankyrin-related ADP-ribose polymerase (TNKS); TNKS2 Mouse …

    Published on 4/25/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Melanoma c-Mer proto-oncogene tyrosine kinase (MERTK) In vitro and mouse studies suggest MERTK inhibitors …

    Published on 4/25/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Ovarian cancer ATPase class VI type 11B (ATP11B) Mouse and cell culture studies suggest inhibiting ATP11B …

    Published on 4/25/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Atherosclerosis Not applicable Patient and mouse studies suggest inhibiting intestinal …

    Published on 4/25/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Cardiomyopathy; heart failure MAP kinase 1 (MAPK1; ERK-2) Rodent studies suggest inhibiting …

    Published on 4/25/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Cardiovascular disease ATP-binding cassette sub-family G member 4 (ABCG4); lyn kinase (LYN); …

    Published on 4/25/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Cytomegalovirus (CMV) ATP-binding cassette sub-family C member 1 (ABCC1; MRP; MRP1) Cell culture…

    Published on 4/25/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Musculoskeletal disease Osteoporosis Peroxisome proliferation-activated receptor-d (PPARD; PPARd) In vitro and …

    Published on 4/25/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Neurology IL-5 In vitro and mouse studies suggest inhibiting eosinophil toxicity could help treat …

    Published on 4/25/2013

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993

Log In


Forgot password  |  Forgot Login


If you are a subscriber, but have forgotten or never received a password, please click above to receive a new one.

SciBX: Science-Business eXchange

BioCentury's weekly translational science journal, published in collaboration with Nature Publishing Group:

  • Selects from hundreds of scientific papers published each week to identify early opportunities for investment, alliances and partnerships
  • Reports on the most commercially relevant developments